Compare Cigna Corp (CI) vs Kinross Gold Corporation (KGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Kinross Gold Corporation — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Kinross Gold Corporation trades at $27.5 (market cap $32.46B). The key difference: Cigna Corp is far larger — about 2.3× Kinross Gold Corporation's market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| CI | KGC | |
|---|---|---|
Market Cap | $73.56B | $32.46B |
Sector | Health | Basic Materials |
52-Week High | $311.00 | $38.06 |
52-Week Low | $244.41 | $18.70 |
Enterprise Value | $98.27B | $30.54B |
Dividend Yield | 2.24% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Kinross Gold (KGC) trades at $27.64, up 7.88% with strong momentum following recent earnings beats. The stock shows bullish technical signals with robust fundamentals including 37.52% net margins and 36.95% ROE. Recent S&P credit upgrade to 'BBB' and consistent dividend payments support positive sentiment. Valuation remains attractive with P/E of 10.51 and EV/EBITDA of 5.48.
Outlook remains positive with projected revenue growth to $8.5B in 2026 and strong free cash flow generation. Key risks include gold price volatility and operational execution. Analyst consensus favors Buy with $37.20 price target representing 35% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →
